O impacto do tromboembolismo venoso e a profilaxia em pacientes hospitalizados
Nenhuma Miniatura disponível
Data
2022-12-12
Tipo de documento
Artigo Científico
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Ciências da Saúde
Modalidade de acesso
Acesso aberto
Editora
Autores
Silva, Daniela Raquel da
Leite, Maria Edivânia de Oliveira
Orientador
Duarte, Gabriella Mendes
Coorientador
Resumo
O tromboembolismo venoso (TEV) acomete a trombose venosa profunda (TVP)
até o tromboembolismo pulmonar (TEP), conforme a gravidade crescente de
acometimento, causa o motivo mais frequente de óbitos intra-hospitalares em todo
mundo. Essa patologia é desenvolvida na corrente sanguínea pela coagulação e
consiste na formação de uma massa sólida composta por uma rede de fibrina na qual
estão elementos figurados de sangue (glóbulos vermelhos, glóbulos brancos e
plaquetas), desse modo, quando ocorre na parede de um vaso, o processo recebe o
nome de trombo. Diversos estudos clínicos e científicos comprovados têm mostrado
que o anticoagulante é eficaz para profilaxia e tratamento associado aos distúrbios
trombóticos de coagulação. Nos últimos anos foram introduzidos novos
anticoagulantes para revolucionar e beneficiar os doentes. Entretanto, apesar dos
protocolos de profilaxia dessa doença existirem a muito tempo ainda há uma limitação
em seu uso, pelo menos 80% das pessoas que apresentam tromboembolismo venoso
possuem algum fator de risco identificável, podendo ter sido reconhecido antes do
surgimento do problema para realização da tromboprofilaxia. A estratificação de risco
é fundamental para justificar os custos e reduzir as complicações trombóticas nos
pacientes admitidos em ambiente hospitalar, pois prevenção é a forma mais
apropriada para conter o impacto que a doença ocasiona aos pacientes
hospitalizados. Assim, o objetivo desse trabalho é evidenciar se há segurança e a
eficácia da utilização da profilaxia do tromboembolismo venoso, como também
identificar a importância do profissional farmacêutico no acompanhamento desses
pacientes com a doença e compreender os impactos do tratamento.
Venous thromboembolism (VTE) ranges from deep vein thrombosis (DVT) to pulmonary thromboembolism (PTE), depending on the increasing severity of involvement, causing the most frequent reason for in-hospital deaths worldwide. This pathology is developed in the blood by clotting and consists of the formation of a continuous mass composed of a fibrin network acting as formed elements of blood (red blood cells, white blood cells and platelets). The process is called a thrombus. Clinical studies and scientific studies have various effects for prophylaxis of clotting disorders. In recent years, new anticoagulants have been revolutionized for the beneficiary patient. However, despite this, the disease protocols of the less laxative protocols still exist in a limitation in their time of people who have a lot that will present venous use of some risk factor, and may have been recognized before the problem even do the implementation of, thromboem for implementation of thromboem thromboprophylaxis. Risk stratification is essential to justify costs and reduce thrombotic complications in hospital admissions, as prevention is the most appropriate way to contain the impact that an occasional illness has on hospitalized patients. Thus, the objective of this work is to show if there is safety and a treatment operation for the use of venous thromboembolism prophylaxis, as well as to identify the importance of the professional in the follow-up of patients with a disease and to understand the impacts of the disease.
Venous thromboembolism (VTE) ranges from deep vein thrombosis (DVT) to pulmonary thromboembolism (PTE), depending on the increasing severity of involvement, causing the most frequent reason for in-hospital deaths worldwide. This pathology is developed in the blood by clotting and consists of the formation of a continuous mass composed of a fibrin network acting as formed elements of blood (red blood cells, white blood cells and platelets). The process is called a thrombus. Clinical studies and scientific studies have various effects for prophylaxis of clotting disorders. In recent years, new anticoagulants have been revolutionized for the beneficiary patient. However, despite this, the disease protocols of the less laxative protocols still exist in a limitation in their time of people who have a lot that will present venous use of some risk factor, and may have been recognized before the problem even do the implementation of, thromboem for implementation of thromboem thromboprophylaxis. Risk stratification is essential to justify costs and reduce thrombotic complications in hospital admissions, as prevention is the most appropriate way to contain the impact that an occasional illness has on hospitalized patients. Thus, the objective of this work is to show if there is safety and a treatment operation for the use of venous thromboembolism prophylaxis, as well as to identify the importance of the professional in the follow-up of patients with a disease and to understand the impacts of the disease.
Palavras-chave
Tromboembolismo venoso, Tromboembolismo pulmonar, Trombose venosa profunda, Tromboprofilaxia, Anticoagulantes